Life Science REIT PLC (LABS)
Category Property - Direct UK
Some Investment Trusts include direct costs as part of their Ongoing charge, such as the annual management charge. For those that show Ongoing charges as 0% or a dash please review the investment literature for details on the charges that will apply. The Financial Conduct Authority will review this in 2025.
If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice.
If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice.
Sell
41.50p
Buy
42.50p
-0.50p (-1.18%)
Discount/Premium
-44.01%
Estimated NAV
75.916p
Prices updated at 28 May 2025, 16:36 BST
| Prices minimum 15 mins delay
Prices in GBX
Investment objective
The Company will seek to achieve its investment objective by investing in a diversified portfolio of properties across the UK which are typically leased or intended to be leased to tenants operating in, or providing a benefit to, the life science sector. Life science is the branch of sciences concerned with the study of living organisms. This encompasses the study of the breadth of life processes, and the structure and behaviour of living things. Companies operating in the life science sector include, but are not limited to, those involved in the innovation, development and/or production of assets directly or indirectly for human health purposes.
Important documents: Please ensure that you have read the Key Information Document/Technical Guide
, Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.
- Key stats
- Price
- Performance
- Charges & documents
- Shares & trades
- Dividends
- Portfolio
- News & dates
- Trust info
- Director info
| 42.50 | |
| Launch date | 19 Nov 2021 |
| 43.00p - 41.60p | |
| 47.10p - 31.30p | |
| 75.10 as of 31 Dec 2024 | |
| Ongoing charge audited (%) | 1.8 |
| 2.55 | |
| 0.00 | |
| 2.72 | |
| 413,087.29 | |
| 350.00m | |
| 147.00m | |
| 138.82 | |
| Semi-Annually | |
| £374.41m | |
| £256.90m | |
| -48.22 | |
| -50.89 | |
| -34.77 | |
| Fund comparative index | No benchmark |
| SA | |
| 0.87m | |
| 0.33m | |
| GB00BP5X4Q29 |
Please note that some funds may have small additional incidental charges that are not shown here. Where these charges do exist they are included within the variable ongoing costs in the Pre-sale Illustration.
